Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NONINVASIVE DETECTION OF FETAL ANEUPLOIDY IN EGG DONOR PREGNANCIES
Document Type and Number:
WIPO Patent Application WO/2014/099919
Kind Code:
A3
Abstract:
The present invention provides assay systems and methods for determining the percent fetal contribution of cell-free DNA in a maternal sample from a pregnant female with an egg donor pregnancy. Further provided, are assay systems and methods for determining a statistical likelihood of the presence or absence of a fetal aneuploidy in a maternal sample using a determined percent fetal cell-free DNA in the sample.

Inventors:
OLIPHANT ARNOLD (US)
WANG ERIC (US)
STRUBLE CRAIG (US)
Application Number:
PCT/US2013/075683
Publication Date:
October 09, 2014
Filing Date:
December 17, 2013
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ARIOSA DIAGNOSTICS INC (US)
International Classes:
C12Q1/68; C40B20/00; G16B20/00; G16B20/10; G16B20/20; G16B30/00
Domestic Patent References:
WO2010033578A22010-03-25
Foreign References:
US20110124515A12011-05-26
US20120122701A12012-05-17
US20120053062A12012-03-01
US20120034603A12012-02-09
Other References:
SPARKS ET AL.: "Noninvasive prenatal detection and selective analysis of cell -free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18", AM J OBSTET GYNECOL, vol. 206, no. 4, April 2012 (2012-04-01), pages 319.E1 - 319.E9, XP055024123
ASHOOR ET AL.: "Fetal fraction in maternal plasma cell -free DNA at 11-13 weeks' gestation: effect of maternal and fetal factors.", FETAL DIAGN THER, vol. 31, no. 4, 4 May 2012 (2012-05-04), pages 237 - 243, XP055257876
Attorney, Agent or Firm:
BRASHEARS, Sarah (475 N. Whisman Road Suite 40, Mountain View CA, US)
Download PDF: